Global Kaposi Sarcoma Market 2017-2021

Tuesday, May 9, 2017 Research News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, May 8, 2017 /PRNewswire/ -- About Kaposi Sarcoma Kaposi sarcoma is a multicentral tumor. The tumor is caused

by Kaposi sarcoma-associated herpesvirus (KSHV) also known as human herpesvirus 8 (HHV8). It can occur as endemic, classic, epidemic, and iatrogenic forms. Epidemic or acquired immune deficiency syndrome (AIDS)-associated form of treatment is one of
the most prevalent types followed in the treatment of Kaposi sarcoma globally. The diagnosis is done by biopsy, and major treatment types include chemotherapy, HAART, and immunotherapy. HAART is the most common type of treatment due to a high prevalence rate of AIDS-associated Kaposi sarcoma. Download the full report: https://www.reportbuyer.com/product/4886912/Technavio's analysts forecast the global Kaposi sarcoma market to grow at a CAGR of 2.46% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global Kaposi sarcoma market for 2017-2021. To calculate the market size, the report considers the sales of both generic as well as branded drugs. The market is divided into the following segments based on geography: • Americas • APAC • EMEA Technavio's report, Global Kaposi Sarcoma Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors • Bristol-Myers Squibb • GlaxoSmithKline • Johnson & Johnson • Merck Other prominent vendors • Eli Lilly • Pfizer Market driver • Rising number of organ transplants • For a full, detailed list, view our report Market challenge • High cost of treatment • For a full, detailed list, view our report Market trend • Increasing consolidation in the cancer treatment market • For a full, detailed list, view our report Key questions answered in this report • What will the market size be in 2021 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report. Methodology Download the full report: https://www.reportbuyer.com/product/4886912/About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.comFor more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-kaposi-sarcoma-market-2017-2021-300453692.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook